Search

Search Results

• 

  Increased plasma lipocalin-2 levels correlate with disease severity and may be a marker of acute inflammatory response in patients with psoriasis

  Chuyen Thi Hong Nguyen, Oanh Phan Tram Nguyen

  21-11-2022

  https://doi.org/10.4081/dr.2022.9469

  1215

  PDF: 501

  HTML: 30

• Natural language processing of online support group postings reveals patients’ perspectives on strategies for managing psoriasis

  Karan Rajalingam, Phillip M. Johansen, Nicole J. Levin, Jerry Qi, Oge Marques

  11-09-2023

  https://doi.org/10.4081/dr.2023.9824

  814

  PDF: 471

  HTML: 28
• 

  Erythrodermic psoriasis treated with apremilast

  John Arcilla, Daniel Joe, Johnathan Kim, Yohanan Kim, VuAnh N. Truong, Navin Jaipaul

  19-09-2016

  https://doi.org/10.4081/dr.2016.6599

  2000

  PDF: 918

  HTML: 597
• 

  Mucocutaneous presentations of consultant critical and non-critical cases of admitted COVID-19 patients, outpatients, and vaccine-associated dermatoses: a clinical atlas and a large original study of two general COVID-19 centers from Iran

  Afsaneh Sadeghzadeh-Bazargan, Azadeh Goodarzi

  23-05-2023

  https://doi.org/10.4081/dr.2023.9473

  915

  PDF: 410

  SUPPLEMENTARY FILE: 116

  HTML: 19

• A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks

  Luciano Ibba, Luigi Gargiulo, Giulia Pavia, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

  06-06-2023

  https://doi.org/10.4081/dr.2023.9722

  717

  PDF: 415

  HTML: 14

• Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

  Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

  13-09-2023

  https://doi.org/10.4081/dr.2023.9839

  2419

  PDF: 929

  HTML: 26

• Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

  Angela Fico, Edoardo Mortato, Claudia Paganini, Marina Talamonti, Cosimo Di Raimondo, Dionisio Silvaggio, Luca Bianchi, Marco Galluzzo

  30-05-2025

  https://doi.org/10.4081/dr.2025.10414

  335

  PDF: 196
• 

  Autoinflammatory diseases: what is behind them and what is new?

  Michele Maalouly, Serena Saade, Mazen Kurban

  29-12-2022

  https://doi.org/10.4081/dr.2023.9625

  1671

  PDF: 507

  HTML: 129
• 

  Polymorphic eruption of pregnancy

  Vjosa A. Zejnullahu, Valon A. Zejnullahu

  03-08-2022

  https://doi.org/10.4081/dr.2022.9546

  1189

  PDF: 568

  HTML: 18
• 

  Facial pruritic skin rash in a Nigerian boy with atopic dermatitis

  Gianmaria Viglizzo, Astrid Herzum, Lodovica Gariazzo, Corrado Occella

  06-06-2023

  https://doi.org/10.4081/dr.2023.9584

  544

  PDF: 297

  HTML: 25
• 

  Mortality risk factors in febrile ulceronecrotic Mucha- Habermann disease: a systematic review of therapeutic outcomes and complications

  Vasiliki Tasouli-Drakou, May Nguyen, Hannah Guinn, Omron Hassan, Sneha Butala, Sheshanna Phan

  21-11-2022

  https://doi.org/10.4081/dr.2022.9492

  1631

  PDF: 640

  HTML: 82